Discover the complete record of transactions filed by 김석종, Directeur Exécutif. Insider active across 2 companies, notably 제이투케이바이오. In total, 17,943 disclosures have been recorded. Activity tracked since 4 March 2026. The latest transaction was disclosed on 4 March 2026 (Purchase). Regulator: DART (FSS). The full history is openly available.
Kim Seok-jong is an Executive Director at J2K Bio. He oversees the company's operations and plays a key role in implementing growth strategies. With his expertise, Kim is a valuable asset to the organization.